ArticlePloS one2017

Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.

Jeannine M Refos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.